Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

The missing ‘I’ in drug research and the epistemic justice of disclosure

While there is a growing body of ethnography with people who use drugs (PWUD), researchers who are themselves out as drug users—and their unofficial expertise—are largely absent.
Commentary | 2021
Equity, Advocacy, About PWUD, Illegal drugs, Peer/PWLLE program involvement

Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005-2019

There is evidence of change in recent substance type associated with morbidity and mortality.
Original research | 2022
Overdose, Mortality, Harm reduction, About PWUD, Illegal drugs, Stimulants

Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence

The idea that cannabis is a ‘gateway drug’ to more harmful substances such as opioids is highly controversial, yet has substantially impacted policy, education and how we conceptualize substance use.
Lit review | 2022
Policy/Regulatory, About PWUD, Illegal drugs

Wounds Canada

Webpage | 2022
Wrap-around services, Advocacy, About prescribers, Social services, Chronic pain, Injecting drugs

Additional Insights: Through the Autism Lens

Handout | 2021
Peer/PWLLE program involvement

Associations between naloxone prescribing and opioid overdose among patients with acute and chronic pain conditions

To assess whether naloxone prescribing in clinical contexts targeted pain patients most at risk for opioid overdose.
Original research | 2022
Overdose, Mortality, Harm reduction, About prescribers, Outcomes, Chronic pain

Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19

Audiovisual telehealth has been shown to be effective for buprenorphine maintenance treatment prior to COVID-19, but use of telehealth for buprenorphine treatment initiation, and the use of audio-only
Original research | 2022
Equity, About prescribers, Substitution/OAT, Digital health

Chronic pain, prescribed opioids and overdose risk: a qualitative exploration of the views of affected individuals and family members

Explored how individuals and family members perceive the issue of overdose in relation to opioid analgesics, and their views of overdose prevention and potential interventions.
Original research | 2022
Overdose, Safer supply, About PWUD, Chronic pain

Cost-Effectiveness and Guidelines for Opioid Substitution Treatment

Examine the cost-effectiveness of SROM, hydromorphone, diacetylmorphine, and fentanyl in opioid use disorder, and describe the evidence-based guidelines for the use of these treatments
Lit review | 2021
Clinical guidance, Evidence base, Safer supply, About prescribers, Substitution/OAT

Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019–April 2020

In Toronto, Ontario, Canada, a multi-site drug checking service (DCS) pilot project was launched in October 2019.
Original research | 2022
Wrap-around services, Illegal drugs, Drug checking

Enquête canadienne sur l'alcool et les drogues : fichier de microdonnées à grande diffusion

Ce produit est destiné aux utilisateurs qui préfèrent réaliser leur propre analyse et qui s'intéressent à des sous-groupes particuliers de la population ou qui désirent effectuer des croisemements de
Webpage | 2021
Evidence base, About PWUD, Illegal drugs

Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey

Drug overdoses surged during the COVID-19 pandemic, underscoring the need for expanded and accessible substance use disorder (SUD) treatment.

Original research | 2022
About PWUD, Substitution/OAT, Digital health, Carries/take-home doses

Funding and management of naloxone programs in Canada

This Environmental Scan provides an overview of how naloxone is made available in Canadian jurisdictions, with a focus on take-home naloxone programs.
Report | 2018
Overdose, Harm reduction, Policy/Regulatory, Wrap-around services, About pharmacists

Guide for Injecting Tablet Medication

A resource for anyone who is injecting tablet medications (pills) and would like to do so more safely.

Video | 2020
Harm reduction, About PWUD, Injecting drugs

Homelessness and publicly funded substance use disorder treatment in California, 2016–2019: Analysis of treatment needs, level of care placement, and outcomes

The objective of this paper is to develop a better understanding of the SUD services that PEH receive in publicly funded treatment programs by (1) describing the characteristics and needs of the PEH p
Original research | 2021
Wrap-around services, About PWUD, Outcomes, Poverty, Housing, Legal system/law enforcement, Illegal drugs, Mental health

Impact of participation in a peer-led overdose program for people who use drugs

This study explores the personal impact, including benefits and apprehensions, for PWUD who participated in a peer-led overdose prevention program and did not intervene post-training.
Original research | 2022
Overdose, Harm reduction, About PWUD, Outcomes, Illegal drugs, Peer/PWLLE program involvement, Social benefits

Interim opioid agonist treatment for opioid addiction: a systematic review

The study’s objective is to review the impact of interim opioid agonist treatment (OAT), a short-term approach for patients awaiting standard OAT, in terms of treatment retention, access to standard O
Lit review | 2022
Harm reduction, About PWUD, Substitution/OAT, Transitions in care/treatment

Mal/adaptations: A qualitative evidence synthesis of opioid agonist therapy during major disruptions

Opioid agonist therapy (OAT) has been severely disrupted by the COVID-19 pandemic.
Lit review | 2021
Harm reduction, Policy/Regulatory, Equity, About prescribers, About PWUD, Barriers and enablers

Mobile low-threshold buprenorphine integrated with infectious disease services

In 2018, the Baltimore City Health Department launched a mobile clinic called Healthcare on The Spot, which offers low-threshold buprenorphine services integrated with health care services to meet the
Original research | 2022
Harm reduction, Wrap-around services, Social services, Outcomes, Substitution/OAT

Overdose deaths and the COVID-19 pandemic in British Columbia, Canada

This analysis reports on changes in the profile of people who have died of overdose since BC's declaration of COVID-19 as a public health emergency on 17 March 2020.
Original research | 2021
Overdose, Mortality, About PWUD, Outcomes, Illegal drugs, Sex/Gender

Refine Your Search

Keywords
Format
Region